![93074-04-5 | Milbemycin A4 Oxime | (6R,25R)-5-Demethoxy-28-deoxy-6,28-epoxy-25-ethyl-5-(hydroxyimino)milbemycin B Spiro[11,15-methano-2H,13H,17H-furo[4,3,2-pq][2,6]benzodioxacyclooctadecin-13,2'-[2H]pyran], Milbemycin B deriv.; 5-Ketomilbemycin A4 ... 93074-04-5 | Milbemycin A4 Oxime | (6R,25R)-5-Demethoxy-28-deoxy-6,28-epoxy-25-ethyl-5-(hydroxyimino)milbemycin B Spiro[11,15-methano-2H,13H,17H-furo[4,3,2-pq][2,6]benzodioxacyclooctadecin-13,2'-[2H]pyran], Milbemycin B deriv.; 5-Ketomilbemycin A4 ...](https://www.trc-canada.com/prod-img/M344293.png)
93074-04-5 | Milbemycin A4 Oxime | (6R,25R)-5-Demethoxy-28-deoxy-6,28-epoxy-25-ethyl-5-(hydroxyimino)milbemycin B Spiro[11,15-methano-2H,13H,17H-furo[4,3,2-pq][2,6]benzodioxacyclooctadecin-13,2'-[2H]pyran], Milbemycin B deriv.; 5-Ketomilbemycin A4 ...
![CAS No : 129496-10-2| Chemical Name : Milbemycin Oxime| Product Name : Milbemycin Oxime - API | Pharmaffiliates CAS No : 129496-10-2| Chemical Name : Milbemycin Oxime| Product Name : Milbemycin Oxime - API | Pharmaffiliates](https://www.pharmaffiliates.com/pimages/PA4068000.jpg)
CAS No : 129496-10-2| Chemical Name : Milbemycin Oxime| Product Name : Milbemycin Oxime - API | Pharmaffiliates
![Efficacy of moxidectin 6-month injectable and milbemycin oxime/lufenuron tablets against naturally acquired toxocara canis infections in dogs. | Semantic Scholar Efficacy of moxidectin 6-month injectable and milbemycin oxime/lufenuron tablets against naturally acquired toxocara canis infections in dogs. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/76e795944a0a383c50e6b20913f2b85af2874507/3-Table1-1.png)
Efficacy of moxidectin 6-month injectable and milbemycin oxime/lufenuron tablets against naturally acquired toxocara canis infections in dogs. | Semantic Scholar
![Effectiveness of a novel orally administered combination drug product containing milbemycin oxime and lotilaner (Credelio® Plus) for the treatment of larval and immature adult stages of Ancylostoma caninum in experimentally infected dogs Effectiveness of a novel orally administered combination drug product containing milbemycin oxime and lotilaner (Credelio® Plus) for the treatment of larval and immature adult stages of Ancylostoma caninum in experimentally infected dogs](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13071-021-04761-y/MediaObjects/13071_2021_4761_Figa_HTML.png)
Effectiveness of a novel orally administered combination drug product containing milbemycin oxime and lotilaner (Credelio® Plus) for the treatment of larval and immature adult stages of Ancylostoma caninum in experimentally infected dogs
![Cat Kitten Heartworm Milbemycin oxime, Shampoo Bottles 23 0 1, cat Like Mammal, pet, whiskers png | PNGWing Cat Kitten Heartworm Milbemycin oxime, Shampoo Bottles 23 0 1, cat Like Mammal, pet, whiskers png | PNGWing](https://w7.pngwing.com/pngs/760/447/png-transparent-cat-kitten-heartworm-milbemycin-oxime-shampoo-bottles-23-1-cat-like-mammal-pet-whiskers.png)
Cat Kitten Heartworm Milbemycin oxime, Shampoo Bottles 23 0 1, cat Like Mammal, pet, whiskers png | PNGWing
![CEVA LAUNCHES FIRST FDA-APPROVED GENERIC OF MILBEMYCIN OXIME IN U.S. / News Releases & Articles About Ceva / News & Media / Ceva USA CEVA LAUNCHES FIRST FDA-APPROVED GENERIC OF MILBEMYCIN OXIME IN U.S. / News Releases & Articles About Ceva / News & Media / Ceva USA](https://country.cdn.cevaws.com/var/ezflow_site/storage/images/_aliases/large/media/ceva-usa/images/milbeguard_package_image/2027105-1-eng-US/MilbeGuard_package_image.jpg)
CEVA LAUNCHES FIRST FDA-APPROVED GENERIC OF MILBEMYCIN OXIME IN U.S. / News Releases & Articles About Ceva / News & Media / Ceva USA
![Structural elucidation of major degradation products of milbemycin oxime drug substance using LC-MS and NMR - ScienceDirect Structural elucidation of major degradation products of milbemycin oxime drug substance using LC-MS and NMR - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0731708522002837-gr1.jpg)
Structural elucidation of major degradation products of milbemycin oxime drug substance using LC-MS and NMR - ScienceDirect
![129496-10-2 | Milbemycin Oxime (Mixture of Milbemycin Oxime A3 and Milbemycin Oxime A4, 20:80) | Oxime Milbemycin | C₃₁H₄₃NO₇ (A3:20%) and C₃₂H₄₅NO₇ (A4:80%) | TRC 129496-10-2 | Milbemycin Oxime (Mixture of Milbemycin Oxime A3 and Milbemycin Oxime A4, 20:80) | Oxime Milbemycin | C₃₁H₄₃NO₇ (A3:20%) and C₃₂H₄₅NO₇ (A4:80%) | TRC](https://www.trc-canada.com/prod-img/M344280.png)